July 01, 2013 10:35 pm | Updated November 16, 2021 10:21 pm IST - NEW DELHI:
The Tamil Nadu State branch of the Indian Medical Association (IMA) has withdrawn the letter of caution sent to its members in prescribing the drugs manufactured by Ranbaxy Laboratories.
After due verification, and based on reports of the Drug Controller of India, the World Health Organization, and the Supreme Court of India, the Indian Medical Association Tamil Nadu State Branch (IMATNSB) is convinced that there is no issue on the safety of these drugs.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
